The £60 million available will go to support commercial-scale manufacturing investments by companies at the leading-edge of innovation, from cell and gene therapies and earlier and better diagnostic technologies, to medical devices. 

The funding for manufacturing investments will be distributed through the new Life Sciences Innovative Manufacturing Fund (LSIMF), following the success of the earlier Medicines and Diagnostics Manufacturing Transformation Fund.

Source: https://www.gov.uk/government/publications/life-sciences-innovative-manufacturing-fund-lsimf?utm_source=Digital+Health+Ecosystem&utm_campaign=ef10791264-EMAIL_CAMPAIGN_2019_10_04_07_28_COPY_01&utm_medium=email&utm_term=0_b4e89497d1-ef10791264-567962142&mc_cid=ef10791264&mc_eid=2464af25c2